Crossmark

Thalidomide and its metabolite 5‐hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF

Crossref DOI link: https://doi.org/10.15252/embj.2020105375

Published Online: 2021-01-20

Published Print: 2021-02-15

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Yamanaka, Satoshi https://orcid.org/0000-0001-8825-7481
Murai, Hidetaka

Saito, Daisuke

Abe, Gembu

Tokunaga, Etsuko https://orcid.org/0000-0003-0621-3798
Iwasaki, Takahiro

Takahashi, Hirotaka

Takeda, Hiroyuki

Suzuki, Takayuki

Shibata, Norio https://orcid.org/0000-0002-3742-4064
Tamura, Koji

Sawasaki, Tatsuya https://orcid.org/0000-0002-7952-0556
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP19am0101077)

Takeda Science Foundation

Japan Society for the Promotion of Science (JP16H06579, JP17J08477, JP16H04729, JP19H03218, JP17H06112, JP18H02446, JP18H04811, JP18H04756, JP20H05024)
License Information

Version of Record valid from 2021-01-20
More Information

Publication History

Received: 2020-04-22

Accepted: 2020-11-30

Published: 2021-01-20